Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AdiraMedica Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (143)
Cancellation by sponsor (41)
Prescription medicine registration (3)

Date

2026 (15)
2025 (19)
2024 (20)
2023 (4)
2022 (50)
2021 (11)
2020 (23)
2019 (18)
2018 (27)

Search

Sponsor content

187 result(s) found, displaying 21 to 30

ADSILVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle (407842)

28 March 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ADSILVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle.
AMSILVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle (407840)

28 March 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMSILVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle.
SILDAMVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle (407841)

28 March 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SILDAMVIG sildenafil (as citrate) 12.5 milligram/actuation oral liquid suspension bottle.
TADALAFIL LUPIN tadalafil 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

1 September 2025

Cancellation by sponsor

Requested by AdiraMedica Pty Ltd
TADALAFIL LUPIN tadalafil 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

1 September 2025

Cancellation by sponsor

Requested by AdiraMedica Pty Ltd
RELEVA FORTE hyoscine butylbromide 20 mg tablet blister pack (470210)

25 November 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RELEVA FORTE hyoscine butylbromide 20 mg tablet blister pack.
RELEVA hyoscine butylbromide 10 mg tablet blister pack (469367)

19 November 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RELEVA hyoscine butylbromide 10 mg tablet blister pack.
PHARMACY HEALTH PROMETHAZINE 25 promethazine hydrochloride 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2025

Cancellation by sponsor

Requested by AdiraMedica Pty Ltd
TERRYWHITE CHEMMART STOMACH RELIEF FORTE hyoscine butylbromide 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2025

Cancellation by sponsor

Requested by AdiraMedica Pty Ltd
TerryWhite Chemmart Ibuprofen Sodium ibuprofen sodium dihydrate 256mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 May 2025

Cancellation by sponsor

Requested by AdiraMedica Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.